Why have Scientific Regulators not looked more closely at Embalmers Clots?

Raised important questions about the response of scientific regulators to embalmers’ clots. • 00:00

Retired Air Force Major with extensive experience in engineering and data analysis. • 02:04

Approached pandemic data with a unique perspective and relevant questions. • 02:13

Worked on advanced aircraft technology including the F-117 Stealth fighter. • 03:59

Transitioned from Actuarial work to military for adventure and love for country. • 04:08

Married to a woman from Kenya, showcasing a diverse and exciting life. • 04:44

Utilized flat surfaces and special materials for radar evasion in aircraft design. • 05:06

Proud to have contributed to the advancement of stealth technology. • 06:07

Initial skepticism towards Imperial College model due to overestimation of virus lethality. • 6:33

Data analysis from UK showed problems with medical interventions in 2021. • 7:19

Discovery of embalmers clots in November 2021 raised further doubts. • 8:05

Early prevalence studies in California indicated underestimation of COVID-19 cases. • 8:17

Vaccine effectiveness questioned as breakthrough cases showed higher fatality rates. • 11:05

Contradictions in messaging about pandemic being mainly among the unvaccinated. • 11:46

Decision not to take vaccine based on data analysis and skepticism towards official narratives. • 12:05

Discovery of white fibrous clots by embalmers triggers interest in investigatio. • 12:26

Embalmer’s statement at Ohio conference leads to collaboration and survey initiativ. • 13:31

Curiosity, personal connections, and free time drive retired individual to pursue surve. • 16:22

Suspicion of regulatory bodies and mainstream media reluctance to explore potential vaccine lin. • 17:06

Survey conducted anonymously with embalmers worldwide to gather data on white fibrous clot. • 17:11

Survey aimed to understand the unexpected presence of white fibrous clots during the embalming proces. • 17:18

Embalming room privacy and potential link to COVID-19 vaccines led to some hesitation in participating in the surve. • 18:04

Survey results did not show regional patterns in the occurrence of white fibrous clot. • 19:06

Embalming process involves infusing chemical fluid to preserve bodies for funeral. • 19:30

Main injection sites where embalmers found white fibrous clots were in the neck and pelvis are. • 20:36

Distinguished between traditional clots like grape jelly and chicken fat clots versus new white fibrous clot. • 21:03

White fibrous clots are larger, tougher, and more rubbery compared to traditional clot. • 21:21

Survey conducted in USA between December 2022 and January 2023 using top-down and bottom-up approaches. • 22:11

Email sent to embalmers asking for observations of white fibrous clots, ensuring anonymity. • 22:59

Survey questions focused on observations of clots without mentioning COVID or vaccines to avoid bias. • 24:30

66% of 179 respondents reported observing white fibrous clots in corpses they embalmed. • 25:07

Possible reasons for some embalmers not observing clots include variations in embalming thoroughness. • 25:26

Clear increase in observations of clots from 2018 to 2022, with significant rise in 2021 and 2022. • 26:29

Survey data collected over five years to analyze trends before and during COVID pandemic. • 26:42

Survey results show correlation between COVID years and increased observations of white fibrous clots. • 27:06

Large increase in white fibrous clots observed in 2021 and 2022, possibly due to supercharging effect from COVID-19 vaccines. • 27:39

Spike protein from COVID-19 vaccines may be produced in the body for months, leading to potential clot formation. • 28:27

Majority of white fibrous structures found in the neck region, a common injection site for embalming. • 29:45

Significant percentage of corpses in 2022 showing large whitish fibrous structures and clots, with some embalmers reporting up to 61-80% occurrence. • 31:52

Experienced embalmers with decades of practice encountering these clots for the first time and still observing them in 2023. • 32:25

Unusual blood clots observed by embalmers are a cause for concern due to their potential pre-death occurrence. • 32:32

Discussion on whether the clots occur pre-death, post-death, or both requires further investigation. • 32:39

The presence of significant clots prior to death could potentially lead to sudden deaths from heart attacks and strokes. • 32:59

Observations of ‘grape jelly’ blood clots and increased blood viscosity in 2020 raise questions about their association with COVID-19 and vaccines. • 35:09

Embalmers have reported seeing an increase in ‘grape jelly’ blood clots, resembling coffee grounds, starting in 2020 and continuing into 2021. • 36:00

The phenomenon of microclotting may be linked to the observed increase in ‘grape jelly’ blood clots among embalmers. • 36:15

The timeframe for the emergence of ‘grape jelly’ blood clots aligns with the onset of COVID-19, suggesting a potential connection. • 37:01

Embalmers’ observations of unusual blood clots warrant further investigation and consideration by scientific regulators. • 37:30

Embalmers are observing white fibers clots in veins and arteries post vaccination. • 37:48

Clots are appearing since 2021 and continuing into 2023, with a significant number of embalmers reporting them. • 38:11

Calls for immediate investigation by FDA and CDC to check the link between COVID-19 vaccines and these clots. • 39:26

Presenter shared data with FDA in January, but no action has been taken by the regulators. • 40:02

Medical community lacks awareness due to limited autopsies, while embalmers are witnessing concerning patterns. • 41:54

Comparison drawn with public reporting balloons to military – regulators should not ignore embalmers’ observations. • 42:45

Concerns raised about the thoroughness of testing and approval processes for vaccines, leading to a loss of trust in regulatory agencies and pharmaceutical companies. • 42:52

High levels of antibodies in vaccinated individuals may lead to the formation of fibrous clots, requiring further examination. • 43:15

Limited scrutiny on mRNA technology and lipid nanoparticle delivery system due to their novelty, despite potential risks. • 47:37

Lack of transparency and individual risk assessment in vaccine mandates, with a call for personalized decision-making based on health profiles. • 48:01

Presentation done systematically adds credibility to findings. • 48:28

Responsibility to investigate abnormalities and reassure the public. • 48:56

Need for rigorous scientific research to determine evidence. • 49:25

Potential implications of fibrous clots on disease risks. • 49:43

Importance of thorough investigation and awareness in the field. • 50:22

Embalmer beliefs and comments on white fibrous clots. • 50:22

Varied responses from embalmers regarding vaccine-related implications. • 51:31

Compelling responses from embalmers without direct mention of COVID or vaccines. • 53:39

Call for scientific regulators to investigate the observed phenomenon. • 53:54

Importance of curiosity and determination in raising questions. • 54:16

Encouragement for public to question and contribute valuable data. • 54:25

Recognition of the value of diverse perspectives in scientific inquiry. • 54:36

Acknowledgment of the need for independent verification of findings. • 54:44

Appreciation for individual bringing attention to the issue. • 54:53

Responsibility to ensure unusual patterns are not overlooked. • 55:08

Hope to see more work from the individual in the future. • 55:16